Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Current Liabilities (2016 - 2025)

PAVmed has reported Total Current Liabilities over the past 5 years, most recently at $14.8 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 58.14% year-over-year to $14.8 million; the TTM value through Dec 2025 reached $14.8 million, down 58.14%, while the annual FY2025 figure was $14.8 million, 58.14% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $14.8 million at PAVmed, up from $10.5 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $55.0 million in Q1 2024 and troughed at $7.6 million in Q4 2021.
  • A 5-year average of $33.0 million and a median of $38.9 million in 2022 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: surged 445.12% in 2022 and later tumbled 82.22% in 2025.
  • Year by year, Total Current Liabilities stood at $7.6 million in 2021, then surged by 445.12% to $41.2 million in 2022, then skyrocketed by 31.5% to $54.2 million in 2023, then plummeted by 34.57% to $35.4 million in 2024, then crashed by 58.14% to $14.8 million in 2025.
  • Business Quant data shows Total Current Liabilities for PAVM at $14.8 million in Q4 2025, $10.5 million in Q3 2025, and $10.5 million in Q2 2025.